The DOI matches its Crossref record; 151 of the 151 references it cites were found in a registry or an index.
NAFLD: A multisystem disease
Open accessAbstract
Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in Western countries that is predicted to become also the most frequent indication for liver transplantation by 2030. Over the last decade, it has been shown that the clinical burden of NAFLD is not only confined to liver-related morbidity and mortality, but there is now growing evidence that NAFLD is a multisystem disease, affecting extra-hepatic organs and regulatory pathways. For example, NAFLD increases risk of type 2 diabetes mellitus (T2DM), cardiovascular (CVD) and cardiac diseases, and chronic kidney disease (CKD). Although the primary liver pathology in NAFLD affects hepatic structure and function to cause morbidity and mortality from cirrhosis, liver failure and hepatocellular carcinoma, the majority of deaths among NAFLD patients are attributable to CVD. This narrative review focuses on the rapidly expanding body of clinical evidence that supports the concept of NAFLD as a multisystem disease. The review discusses the factors involved in the progression of liver disease in NAFLD and the factors linking NAFLD with other extra-hepatic chronic diseases, such as T2DM, CVD, cardiac diseases and CKD. The review will not discuss NAFLD treatments as these are discussed elsewhere in this issue of the Journal. For this review, PubMed was searched for articles using the keywords "non-alcoholic fatty liver disease" or "fatty liver" combined with "diabetes", "cardiovascular (or cardiac) disease", "cardiovascular mortality" or "chronic kidney disease" between 1990 and 2014. Articles published in languages other than English were excluded.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Zhou, Y. J., Li, Y. Y., Nie, Y. Q., Huang, C., & Cao, C. Y. (2011) · Journal of Digestive Diseases · doi:10.1111/j.1751-2980.2011.00571.x · Cited by 93
RetractedDesign and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
Inflammation and insulin resistance
Shoelson, S. E. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29069 · Cited by 4,769
Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity
Browning, J. D., Szczepaniak, L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., Grundy, S. M., & Hobbs, H. H. (2004) · Hepatology · doi:10.1002/hep.20466 · Cited by 3,664
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Romeo, S., Kozlitina, J., Xing, C., Pertsemlidis, A., Cox, D., Pennacchio, L. A., Boerwinkle, E., Cohen, J. C., & Hobbs, H. H. (2008) · Nature Genetics · doi:10.1038/ng.257 · Cited by 3,416
Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.
MATTEONI, C., YOUNOSSI, Z., GRAMLICH, T., BOPARAI, N., LIU, Y., & MCCULLOUGH, A. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70506-8 · Cited by 3,345
Assessing Kidney Function — Measured and Estimated Glomerular Filtration Rate
Stevens, L. A., Coresh, J., Greene, T., & Levey, A. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmra054415 · Cited by 2,952 · cited 1×
“The use of direct measurements of GFR should be encouraged as the creatinine-based equations are not accurate in estimating GFR, especially for patients with severe obesity or cirrhosis [141].”
BackgroundThe Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
Adams, L. A., Lymp, J. F., St. Sauver, J., Sanderson, S. O., Lindor, K. D., Feldstein, A., & Angulo, P. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.04.014 · Cited by 2,890
Endoplasmic reticulum stress and the inflammatory basis of metabolic disease
Hotamisligil, G. S. (2010) · Cell · doi:10.1016/j.cell.2010.02.034 · Cited by 2,802
Systematic review and meta-analysis
(2019) · Providing Information for Health · doi:10.1201/9781315377315-19 · Cited by 2,659
Long-term follow-up of patients with NAFLD and elevated liver enzymes
Ekstedt, M., Franzén, L. E., Mathiesen, U. L., Thorelius, L., Holmqvist, M., Bodemar, G., & Kechagias, S. (2006) · Hepatology · doi:10.1002/hep.21327 · Cited by 2,302 · cited 17×
“Although it is less certain whether simple steatosis increases risk of HCC, it is now becoming clear that NASH is a risk factor for HCC, even in people without cirrhosis [30–32].”
BackgroundResultInfluentialMechanisms for Insulin Resistance: Common Threads and Missing Links
Samuel, V. T., & Shulman, G. I. (2012) · Cell · doi:10.1016/j.cell.2012.02.017 · Cited by 2,294
Ekstedt, M., Hagström, H., Nasr, P., Fredrikson, M., Stål, P., Kechagias, S., & Hultcrantz, R. (2015) · Hepatology · doi:10.1002/hep.27368 · Cited by 2,287 · cited 4×
“2014 [24] Retrospective cohort”
BackgroundInfluentialObesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
Yoshimoto, S., Loo, T. M., Atarashi, K., Kanda, H., Sato, S., Oyadomari, S., Iwakura, Y., Oshima, K., Morita, H., Hattori, M., et al. (2013) · Nature · doi:10.1038/nature12347 · Cited by 2,219
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
Targher, G., Day, C. P., & Bonora, E. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0912063 · Cited by 1,907
Self-citationObesity, Inflammation, and Insulin Resistance
Shoelson, S. E., Herrero, L., & Naaz, A. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.059 · Cited by 1,806 · cited 2×
“atherogenesis and in the development of insulin resistance and NAFLD [54,58,71,72,75,143–145].”
BackgroundProgression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
Anstee, Q. M., Targher, G., & Day, C. P. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.41 · Cited by 1,747
Self-citationHernaez, R., Lazo, M., Bonekamp, S., Kamel, I., Brancati, F. L., Guallar, E., & Clark, J. M. (2011) · Hepatology · doi:10.1002/hep.24452 · Cited by 1,585
Szczepaniak, L. S., Nurenberg, P., Leonard, D., Browning, J. D., Reingold, J. S., Grundy, S., Hobbs, H. H., & Dobbins, R. L. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00064.2004 · Cited by 1,562
The burden of liver disease in Europe: A review of available epidemiological data
Blachier, M., Leleu, H., Peck-Radosavljevic, M., Valla, D.-C., & Roudot-Thoraval, F. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2012.12.005 · Cited by 1,341
Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma: A Weighty Connection
Starley, B. Q., Calcagno, C. J., & Harrison, S. A. (2010) · Hepatology · doi:10.1002/hep.23594 · Cited by 1,336
Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease
Samuel, V. T., Liu, Z.-X., Qu, X., Elder, B. D., Bilz, S., Befroy, D., Romanelli, A. J., & Shulman, G. I. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313478200 · Cited by 1,322 · cited 2×
“In NAFLD, secretion of diabetogenic hepatokines, such as retinol binding protein (RBP)-4, fetuin-A, fibroblast growth factor (FGF)-21; or inflammatory biomarkers such as C-reactive protein (CRP), TNF-a and IL-6 [73] may directly affect risk of incident T2DM by adversely affecting hepatic gluconeogenesis, glycogen synt…”
BackgroundMusso, G., Gambino, R., Cassader, M., & Pagano, G. (2011) · Annals of Medicine · doi:10.3109/07853890.2010.518623 · Cited by 1,293
Insulin sensitivity: Modulation by nutrients and inflammation
Schenk, S., Saberi, M., & Olefsky, J. M. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34260 · Cited by 1,191 · cited 1×
“Journal of Hepatology 201 products (particularly DAGs) is very important in causing ‘resistance’ within the hepatic insulin signaling pathway [61], promoting hepatic inflammation [62–65] and increasing risk of progressive liver disease that occurs with NASH.”
BackgroundThe role of hepatic lipids in hepatic insulin resistance and type 2 diabetes
Perry, R. J., Samuel, V. T., Petersen, K. F., & Shulman, G. I. (2014) · Nature · doi:10.1038/nature13478 · Cited by 1,136
Charlton, M. R., Burns, J. M., Pedersen, R. A., Watt, K. D., Heimbach, J. K., & Dierkhising, R. A. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.06.061 · Cited by 1,106
Yamaguchi, K., Yang, L., McCall, S., Huang, J., Yu, X. X., Pandey, S. K., Bhanot, S., Monia, B. P., Li, Y.-X., & Diehl, A. M. (2007) · Hepatology · doi:10.1002/hep.21655 · Cited by 1,015
Targher, G., Bertolini, L., Padovani, R., Rodella, S., Tessari, R., Zenari, L., Day, C., & Arcaro, G. (2007) · Diabetes Care · doi:10.2337/dc06-2247 · Cited by 992
Self-citationMichelotti, G. A., Machado, M. V., & Diehl, A. M. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.183 · Cited by 974
Beutler, B. A. (2009) · Blood · doi:10.1182/blood-2008-07-019307 · Cited by 840
Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy
Reeder, S. B., Cruite, I., Hamilton, G., & Sirlin, C. B. (2011) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.22580 · Cited by 822
REGULATION OF CERAMIDE PRODUCTION AND APOPTOSIS
Kolesnick, R. N., & Krönke, M. (1998) · Annual Review of Physiology · doi:10.1146/annurev.physiol.60.1.643 · Cited by 803
Kim, D., Kim, R. W., Kim, H. J., & Therneau, T. M. (2013) · Hepatology · doi:10.1002/hep.26156 · Cited by 772
Decreased Survival of Subjects With Elevated Liver Function Tests During A 28-Year Follow-Up
Söderberg, C., Stål, P., Askling, J., Glaumann, H., Lindberg, G., Marmur, J., & Hultcrantz, R. (2010) · Hepatology · doi:10.1002/hep.23314 · Cited by 754
Long-Term Follow-Up of Patients With Nonalcoholic Fatty Liver
Rafiq, N., Bai, C., Fang, Y., Srishord, M., McCullough, A., Gramlich, T., & Younossi, Z. M. (2009) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.11.005 · Cited by 729
Musso, G., Gambino, R., Tabibian, J. H., Ekstedt, M., Kechagias, S., Hamaguchi, M., Hultcrantz, R., Hagström, H., Yoon, S. K., Charatcharoenwitthaya, P., et al. (2014) · PLoS Medicine · doi:10.1371/journal.pmed.1001680 · Cited by 720
Lee, B.-C., & Lee, J. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.05.017 · Cited by 695
Sumida, Y. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i2.475 · Cited by 689
ReviewIs Serum Gamma Glutamyltransferase a Marker of Oxidative Stress?
Lee, D.-H., Blomhoff, R., & Jacobs, D. R. (2004) · Free Radical Research · doi:10.1080/10715760410001694026 · Cited by 666
Aortic-Valve Stenosis — From Patients at Risk to Severe Valve Obstruction
Otto, C. M., & Prendergast, B. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1313875 · Cited by 631
Extrahepatic complications of nonalcoholic fatty liver disease
Armstrong, M. J., Adams, L. A., Canbay, A., & Syn, W.-K. (2014) · Hepatology · doi:10.1002/hep.26717 · Cited by 600
Algra, A., Tijssen, J. G., Roelandt, J. R., Pool, J., & Lubsen, J. (1991) · Circulation · doi:10.1161/01.cir.83.6.1888 · Cited by 592
Targher, G., Bertolini, L., Rodella, S., Tessari, R., Zenari, L., Lippi, G., & Arcaro, G. (2007) · Diabetes Care · doi:10.2337/dc07-0349 · Cited by 579
Self-citationRijzewijk, L. J., van der Meer, R. W., Smit, J. W. A., Diamant, M., Bax, J. J., Hammer, S., Romijn, J. A., de Roos, A., & Lamb, H. J. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.07.062 · Cited by 559 · cited 2×
“[102] found that those with higher intra-hepatic fat content had significantly higher myocardial fat content (i.”
BackgroundNonalcoholic fatty liver disease is a novel predictor of cardiovascular disease
Hamaguchi, M. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i10.1579 · Cited by 542
Ertle, J., Dechêne, A., Sowa, J., Penndorf, V., Herzer, K., Kaiser, G., Schlaak, J. F., Gerken, G., Syn, W., & Canbay, A. (2011) · International Journal of Cancer · doi:10.1002/ijc.25797 · Cited by 518
Molecular Virology of Hepatitis B Virus
Locarnini, S. (2004) · Seminars in Liver Disease · doi:10.1055/s-2004-828672 · Cited by 515
Long term prognosis of fatty liver: risk of chronic liver disease and death
Dam-Larsen, S., Franzmann, M., Andersen, I. B., Christoffersen, P., Jensen, L. B., Sørensen, T. I. A., Becker, U., & Bendtsen, F. (2004) · Gut · doi:10.1136/gut.2003.019984 · Cited by 508
The role of hepatokines in metabolism
Stefan, N., & Häring, H.-U. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.258 · Cited by 500 · cited 2×
“Indeed, NAFLD, especially its necro-inflammatory variant (NASH), may exacerbate hepatic/ peripheral insulin resistance, cause atherogenic dyslipidemia, and release a myriad of pro-inflammatory molecules and vasoactive and thrombogenic molecules that play important roles in the pathophysiology of cardiovascular/cardiac…”
BackgroundNon-alcoholic fatty liver disease: a new and important cardiovascular risk factor?
Bhatia, L. S., Curzen, N. P., Calder, P. C., & Byrne, C. D. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehr453 · Cited by 496
Self-citation(2004) · Seminars in Liver Disease · doi:10.1055/s-2004-823098 · Cited by 481
Insulin resistance, inflammation, and non-alcoholic fatty liver disease
Tilg, H., & Moschen, A. R. (2008) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2008.08.005 · Cited by 473
Radiologic evaluation of nonalcoholic fatty liver disease
Lee, S. S. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i23.7392 · Cited by 426
Cause-specific mortality in type 2 diabetes. The Verona Diabetes Study.
de Marco, R., Locatelli, F., Zoppini, G., Verlato, G., Bonora, E., & Muggeo, M. (1999) · Diabetes Care · doi:10.2337/diacare.22.5.756 · Cited by 405
Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study
Lazo, M., Hernaez, R., Bonekamp, S., Kamel, I. R., Brancati, F. L., Guallar, E., & Clark, J. M. (2011) · BMJ · doi:10.1136/bmj.d6891 · Cited by 395
Targher, G., Bertolini, L., Rodella, S., Zoppini, G., Lippi, G., Day, C., & Muggeo, M. (2008) · Diabetologia · doi:10.1007/s00125-007-0897-4 · Cited by 383
Self-citationOni, E. T., Agatston, A. S., Blaha, M. J., Fialkow, J., Cury, R., Sposito, A., Erbel, R., Blankstein, R., Feldman, T., Al-Mallah, M. H., et al. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.07.052 · Cited by 352
Stepanova, M., & Younossi, Z. M. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.12.039 · Cited by 352
Ix, J. H., & Sharma, K. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009080820 · Cited by 348
Diabetes and cause-specific mortality in a prospective cohort of one million U.S. Adults
Campbell, P. T., Newton, C. C., Patel, A. V., Jacobs, E. J., & Gapstur, S. M. (2012) · Diabetes Care · doi:10.2337/dc12-0002 · Cited by 339
Diacylglycerol Activation of Protein Kinase Cε and Hepatic Insulin Resistance
Jornayvaz, F. R., & Shulman, G. I. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.03.005 · Cited by 317
Targher, G., & Byrne, C. D. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3093 · Cited by 297
Self-citationWong, V. W.-S., Wong, G. L.-H., Yip, G. W.-K., Lo, A. O.-S., Limquiaco, J., Chu, W. C.-W., Chim, A. M.-L., Yu, C.-M., Yu, J., Chan, F. K.-L., et al. (2011) · Gut · doi:10.1136/gut.2011.242016 · Cited by 296
Yang, G., Badeanlou, L., Bielawski, J., Roberts, A. J., Hannun, Y. A., & Samad, F. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.91014.2008 · Cited by 295
Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals
Masuoka, H. C., & Chalasani, N. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12016 · Cited by 283
Ballestri, S. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i7.1724 · Cited by 262
Musso, G., Cassader, M., Olivetti, C., Rosina, F., Carbone, G., & Gambino, R. (2013) · Obesity Reviews · doi:10.1111/obr.12020 · Cited by 254
Leroux, A., Ferrere, G., Godie, V., Cailleux, F., Renoud, M.-L., Gaudin, F., Naveau, S., Prévot, S., Makhzami, S., Perlemuter, G., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.02.028 · Cited by 246
Haring, R., Wallaschofski, H., Nauck, M., Dörr, M., Baumeister, S. E., & Völzke, H. (2009) · Hepatology · doi:10.1002/hep.23135 · Cited by 245
Nonalcoholic Fatty Liver Disease Is a Risk Factor for Type 2 Diabetes in Middle-Aged Japanese Men
Shibata, M., Kihara, Y., Taguchi, M., Tashiro, M., & Otsuki, M. (2007) · Diabetes Care · doi:10.2337/dc07-0792 · Cited by 238
Targher, G., Bertolini, L., Rodella, S., Lippi, G., Zoppini, G., & Chonchol, M. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.05050610 · Cited by 233
Self-citationIncreased Risk of CKD among Type 2 Diabetics with Nonalcoholic Fatty Liver Disease
Targher, G., Chonchol, M., Bertolini, L., Rodella, S., Zenari, L., Lippi, G., Franchini, M., Zoppini, G., & Muggeo, M. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007101155 · Cited by 232
Self-citationSung, K.-C., Jeong, W.-S., Wild, S. H., & Byrne, C. D. (2012) · Diabetes Care · doi:10.2337/dc11-1853 · Cited by 218
Self-citationCKD and Nonalcoholic Fatty Liver Disease
Targher, G., Chonchol, M. B., & Byrne, C. D. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2014.05.019 · Cited by 213
Self-citationPerseghin, G., Lattuada, G., De Cobelli, F., Esposito, A., Belloni, E., Ntali, G., Ragogna, F., Canu, T., Scifo, P., Del Maschio, A., et al. (2008) · Hepatology · doi:10.1002/hep.21983 · Cited by 210
Targher, G., Valbusa, F., Bonapace, S., Bertolini, L., Zenari, L., Rodella, S., Zoppini, G., Mantovani, W., Barbieri, E., & Byrne, C. D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057183 · Cited by 197
Self-citationMaximos, M., Bril, F., Portillo Sanchez, P., Lomonaco, R., Orsak, B., Biernacki, D., Suman, A., Weber, M., & Cusi, K. (2015) · Hepatology · doi:10.1002/hep.27395 · Cited by 195
Effects of nonalcoholic fatty liver disease on the development of metabolic disorders
Fan, J., Li, F., Cai, X., Peng, Y., Ao, Q., & Gao, Y. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04781.x · Cited by 193
Gao, Z., Zhang, J., Kheterpal, I., Kennedy, N., Davis, R. J., & Ye, J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.228874 · Cited by 187 · cited 2×
“In NAFLD, secretion of diabetogenic hepatokines, such as retinol binding protein (RBP)-4, fetuin-A, fibroblast growth factor (FGF)-21; or inflammatory biomarkers such as C-reactive protein (CRP), TNF-a and IL-6 [73] may directly affect risk of incident T2DM by adversely affecting hepatic gluconeogenesis, glycogen synt…”
BackgroundBonapace, S., Perseghin, G., Molon, G., Canali, G., Bertolini, L., Zoppini, G., Barbieri, E., & Targher, G. (2012) · Diabetes Care · doi:10.2337/dc11-1820 · Cited by 183
Self-citationByrne, C. D., & Targher, G. (2014) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.114.303034 · Cited by 179
Self-citationYoon, J. H., Lee, J. M., Joo, I., Lee, E. S., Sohn, J. Y., Jang, S. K., Lee, K. B., Han, J. K., & Choi, B. I. (2014) · Radiology · doi:10.1148/radiol.14132000 · Cited by 175
Stickel, F., & Hellerbrand, C. (2010) · Gut · doi:10.1136/gut.2009.199661 · Cited by 174
Mortality From Chronic Liver Diseases in Diabetes
Zoppini, G., Fedeli, U., Gennaro, N., Saugo, M., Targher, G., & Bonora, E. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.132 · Cited by 172
Self-citationThe Gordian Knot of dysbiosis, obesity and NAFLD
Mehal, W. Z. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.146 · Cited by 171
Risk of chronic kidney disease in patients with non-alcoholic fatty liver disease: Is there a link?
Targher, G., Chonchol, M., Zoppini, G., Abaterusso, C., & Bonora, E. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.11.007 · Cited by 171
Self-citationThe F ramingham risk score and heart disease in nonalcoholic fatty liver disease
Treeprasertsuk, S., Leverage, S., Adams, L. A., Lindor, K. D., Sauver, J. L. S., & Angulo, P. (2012) · Liver International · doi:10.1111/j.1478-3231.2011.02753.x · Cited by 171
Lautamäki, R., Borra, R., Iozzo, P., Komu, M., Lehtimäki, T., Salmi, M., Jalkanen, S., Airaksinen, K. E. J., Knuuti, J., Parkkola, R., et al. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00604.2005 · Cited by 170
Resolution of Fatty Liver and Risk of Incident Diabetes
Sung, K.-C., Wild, S. H., & Byrne, C. D. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1519 · Cited by 169
Self-citationIncreased risk of cardiovascular disease and chronic kidney disease in NAFLD
Bonora, E., & Targher, G. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.79 · Cited by 169
Self-citationChang, Y., Ryu, S., Sung, E., Woo, H.-Y., Oh, E., Cha, K., Jung, E., & Kim, W. S. (2008) · Metabolism · doi:10.1016/j.metabol.2007.11.022 · Cited by 164
Chang, Y., Jung, H.-S., Yun, K. E., Cho, J., Cho, Y. K., & Ryu, S. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.349 · Cited by 163
Cardiac structure and function are altered in adults with non-alcoholic fatty liver disease
Hallsworth, K., Hollingsworth, K. G., Thoma, C., Jakovljević, D. G., MacGowan, G. A., Anstee, Q. M., Taylor, R., Day, C. P., & Trenell, M. I. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.11.015 · Cited by 162
Targher, G., Mantovani, A., Pichiri, I., Mingolla, L., Cavalieri, V., Mantovani, W., Pancheri, S., Trombetta, M., Zoppini, G., Chonchol, M., et al. (2014) · Diabetes Care · doi:10.2337/dc13-2704 · Cited by 162
Self-citationCantley, J. L., Yoshimura, T., Camporez, J. P. G., Zhang, D., Jornayvaz, F. R., Kumashiro, N., Guebre-Egziabher, F., Jurczak, M. J., Kahn, M., Guigni, B. A., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219456110 · Cited by 161
Nonalcoholic steatohepatitis and increased risk of chronic kidney disease
Yasui, K., Sumida, Y., Mori, Y., Mitsuyoshi, H., Minami, M., Itoh, Y., Kanemasa, K., Matsubara, H., Okanoue, T., & Yoshikawa, T. (2011) · Metabolism · doi:10.1016/j.metabol.2010.07.022 · Cited by 159
Park, S. K., Seo, M. H., Shin, H. C., & Ryoo, J.-H. (2013) · Hepatology · doi:10.1002/hep.26183 · Cited by 158
Targher, G., Bertolini, L., Chonchol, M., Rodella, S., Zoppini, G., Lippi, G., Zenari, L., & Bonora, E. (2010) · Diabetologia · doi:10.1007/s00125-010-1720-1 · Cited by 158
Self-citationThe impact of liver fat vs visceral fat in determining categories of prediabetes
Kantartzis, K., Machann, J., Schick, F., Fritsche, A., Häring, H., & Stefan, N. (2010) · Diabetologia · doi:10.1007/s00125-010-1663-6 · Cited by 155
Nine-year incident diabetes is predicted by fatty liver indices: the French D.E.S.I.R. study
Group Study D.E.S.I.R., Balkau, B., Lange, C., Vol, S., Fumeron, F., & Bonnet, F. (2010) · BMC Gastroenterology · doi:10.1186/1471-230x-10-56 · Cited by 153
Robbins, J. A., Nelson, J. C., Rautaharju, P. M., & Gottdiener, J. S. (2003) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.07.014 · Cited by 153
Prognosis of patients with a diagnosis of fatty liver--a registry-based cohort study.
Jepsen, P., Vilstrup, H., Mellemkjær, L., Thulstrup, A. M., Olsen, J. H., Baron, J. A., & Sørensen, H. T. (2003) · PubMed · Cited by 152
A population-based study on the prevalence of NASH using scores validated against liver histology
Hyysalo, J., Männistö, V., Zhou, Y., Arola, J., Kärjä, V. J., Leivonen, M., Juuti, A., Jaser, N., Lallukka, S., Käkelä, P., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.12.009 · Cited by 148
Bae, J. C., Rhee, E., Lee, W., Park, S. E., Park, C., Oh, K. W., Park, S. W., & Kim, S. W. (2011) · Diabetes Care · doi:10.2337/dc10-1991 · Cited by 141
Effects of Hepatic Triglyceride Content on Myocardial Metabolism in Type 2 Diabetes
Rijzewijk, L. J., Jonker, J. T., van der Meer, R. W., Lubberink, M., de Jong, H. W. A. M., Romijn, J. A., Bax, J. J., Roos, A., Heine, R. J., Twisk, J. W. R., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.02.049 · Cited by 137
Targher, G., Mantovani, A., Pichiri, I., Rigolon, R., Dauriz, M., Zoppini, G., Morani, G., Vassanelli, C., & Bonora, E. (2013) · Clinical Science · doi:10.1042/cs20130036 · Cited by 129
Self-citationYamada, T., Fukatsu, M., Suzuki, S., Wada, T., Yoshida, T., & Joh, T. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2009.05998.x · Cited by 126
Whalley, S. A., Puvanachandra, P., Desai, A. M., & Kennedy, H. J. (2007) · Clinical Medicine · doi:10.7861/clinmedicine.7-2-119 · Cited by 124
Ectopic fat, insulin resistance and non-alcoholic fatty liver disease
Byrne, C. D. (2013) · Proceedings of The Nutrition Society · doi:10.1017/s0029665113001249 · Cited by 123
Self-citationWatt, M. J., Barnett, A., Bruce, C. R., Schenk, S., Horowitz, J. F., & Hoy, A. J. (2012) · Diabetologia · doi:10.1007/s00125-012-2649-3 · Cited by 119
Fatty liver is an independent risk factor for the development of Type 2 diabetes in Korean adults
Kim, C., Park, J.-Y., Lee, K.-U., Kim, J. H., & Kim, H. ‐. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02410.x · Cited by 118
Byrne, C. D. (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2012.03732.x · Cited by 118
Self-citationInfluence of non‐alcoholic fatty liver disease on the development of diabetes mellitus
Kasturiratne, A., Weerasinghe, S., Dassanayake, A. S., Rajindrajith, S., Silva, A. P. D., Kato, N., Wickremasinghe, A. R., & de Silva, H. J. (2012) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2012.07264.x · Cited by 114
Left Ventricular Dysfunction in Obese Children and Adolescents With Nonalcoholic Fatty Liver Disease
Pacifico, L., Martino, M. D., Merulis, A. D., Bezzi, M., Osborn, J. F., Catalano, C., & Chiesa, C. (2013) · Hepatology · doi:10.1002/hep.26610 · Cited by 113
Association between nonalcoholic fatty liver disease and coronary artery disease
Arslan, U., Türkoğlu, S., Balcıoğlu, S., Tavıl, Y., Karakan, T., & Çengel, A. (2007) · Coronary Artery Disease · doi:10.1097/mca.0b013e3282583c0d · Cited by 110
Holt, H., Wild, S. H., Wood, P. J., Zhang, J.-L., Darekar, A., Dewbury, K. C., Poole, R., Holt, R. I. G., Phillips, D., & Byrne, C. D. (2005) · Diabetologia · doi:10.1007/s00125-005-0070-x · Cited by 108
Self-citationYilmaz, Y. N., Alahdab, Y. Ö., Yönal, O., Kurt, R., Kedrah, A. E., Çelikel, Ç., Ozdogan, O. C., Duman, D., İmeryüz, N., Avşar, E., et al. (2010) · Metabolism · doi:10.1016/j.metabol.2009.12.012 · Cited by 102
Serum γ-Glutamyl Transferase and Risk of Heart Failure in the Community
Dhingra, R., Gona, P. N., Wang, T. J., Fox, C. S., D’Agostino, R. B., & Vasan, R. S. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.207340 · Cited by 102
Association of nonalcoholic fatty liver disease with QTc interval in patients with type 2 diabetes
Targher, G., Valbusa, F., Bonapace, S., Bertolini, L., Zenari, L., Pichiri, I., Mantovani, A., Zoppini, G., Bonora, E., Barbieri, E., et al. (2014) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2014.01.005 · Cited by 101
Self-citationRelation of Circulating Liver Transaminase Concentrations to Risk of New-Onset Atrial Fibrillation
Sinner, M. F., Wang, N., Fox, C. S., Fontes, J. D., Rienstra, M., Magnani, J. W., Vasan, R. S., Calderwood, A. H., Pencina, M. J., SULLIVAN, L. M., et al. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.09.021 · Cited by 101
Fatty liver incidence and predictive variables
Tsuneto, A., Hida, A., Sera, N., Imaizumi, M., Ichimaru, S., Nakashima, E., Seto, S., Maemura, K., & Akahoshi, M. (2010) · Hypertension Research · doi:10.1038/hr.2010.45 · Cited by 100
Kim, N. H., Park, J., Kim, S. H., Kim, Y. H., Kim, D. H., Cho, G., Baik, I., Lim, H. E., Kim, E. J., Na, J. O., et al. (2014) · Heart · doi:10.1136/heartjnl-2013-305099 · Cited by 100
Alonso, Á., Misialek, J. R., Amiin, M. A., Hoogeveen, R. C., Chen, L. Y., Agarwal, S. K., Loehr, L. R., Soliman, E. Z., & Selvin, E. (2014) · Heart · doi:10.1136/heartjnl-2014-305756 · Cited by 99
Hwang, S. T., Cho, Y. K., Yun, J. W., Park, J. H., Kim, H., Park, D. I., Sohn, C. I., Jeon, W. K., Kim, B., Rhee, E., et al. (2009) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2009.01979.x · Cited by 92
Diagnosis and management of cardiovascular risk in nonalcoholic fatty liver disease
Lonardo, A., Ballestri, S., Targher, G., & Loria, P. (2014) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2015.965143 · Cited by 88
Self-citationSphingolipids: agents provocateurs in the pathogenesis of insulin resistance
Lipina, C., & Hundal, H. S. (2011) · Diabetologia · doi:10.1007/s00125-011-2127-3 · Cited by 83 · cited 1×
“Although in the past, it was thought that ceramide was simply a structural molecule, there is some evidence that an increase in membrane ceramide cause insulin resistance (see review [69] and Fig.”
BackgroundFatigue and autonomic dysfunction in non-alcoholic fatty liver disease
Newton, J. L., Pairman, J., Wilton, K., Jones, D. E. J., & Day, C. P. (2009) · Clinical Autonomic Research · doi:10.1007/s10286-009-0031-4 · Cited by 80
Targher, G., Pichiri, I., Zoppini, G., Trombetta, M., & Bonora, E. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03427.x · Cited by 79
Self-citationRossi, A., Targher, G., Zoppini, G., Cicoira, M., Bonapace, S., Negri, C., Stoico, V., Faggiano, P. M., Vassanelli, C., & Bonora, E. (2012) · Diabetes Care · doi:10.2337/dc12-0134 · Cited by 79
Self-citationLiver: an alarm for the heart?
Mirbagheri, S. A., Rashidi, A., Abdi, S., Saedi, D., & Abouzari, M. (2007) · Liver International · doi:10.1111/j.1478-3231.2007.01531.x · Cited by 78
Singh, G. K., Vitola, B. E., Holland, M. R., Sekarski, T. J., Patterson, B. W., Magkos, F., & Klein, S. (2012) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2012.11.024 · Cited by 74
Morling, J. R., Fallowfield, J. A., Guha, I. N., Nee, L. D., Glancy, S., Williamson, R. M., Robertson, C. M., Strachan, M. W. J., & Price, J. F. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.10.017 · Cited by 73
Markus, M. R. P., Baumeister, S. E., Stritzke, J., Dörr, M., Wallaschofski, H., Völzke, H., & Lieb, W. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.300556 · Cited by 73
Impaired renal function in morbid obese patients with nonalcoholic fatty liver disease
Machado, M. V., Gonçalves, S., Carepa, F., Coutinho, J., Costa, A., & Cortez‐Pinto, H. (2011) · Liver International · doi:10.1111/j.1478-3231.2011.02623.x · Cited by 71
Hyysalo, J., Gopalacharyulu, P. V., Bian, H., Hyötyläinen, T., Leivonen, M., Jaser, N., Juuti, A., Honka, M., Nuutila, P., Olkkonen, V. M., et al. (2013) · Diabetes · doi:10.2337/db13-0774 · Cited by 68
Sert, A., Aypar, E., Pirgon, Ö., Yılmaz, H. S., Odabaş, D., & Tolu, İ. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.03.056 · Cited by 66
γ-Glutamyltransferase, Hepatic Enzymes, and Risk of Incident Heart Failure in Older Men
Wannamethee, S. G., Whincup, P. H., Shaper, A. G., LENNON, L. T., & Sattar, N. A. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.240457 · Cited by 63
Byrne, C. D., & Targher, G. (2013) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0033-1334866 · Cited by 62
Self-citationBonapace, S., Valbusa, F., Bertolini, L., Pichiri, I., Mantovani, A., Rossi, A., Zenari, L., Barbieri, E., & Targher, G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088371 · Cited by 62
Self-citationArase, Y., Suzuki, F., Kobayashi, M., Suzuki, Y., Kawamura, Y., Matsumoto, N., Akuta, N., Kobayashi, M., Sezaki, H., Saito, S., et al. (2011) · Internal Medicine · doi:10.2169/internalmedicine.50.5043 · Cited by 60
Alp, H., Karaarslan, S., Eklioğlu, B. S., Atabek, M. E., Altın, H., & Baysal, T. (2012) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2012.07.846 · Cited by 57
The Association of Fatty Liver and Diabetes Risk.
Okamoto, M., Takeda, Y., Yoda, Y., Kobayashi, K., Fujino, M., & Yamagata, Z. (2003) · Journal of Epidemiology · doi:10.2188/jea.13.15 · Cited by 54
Ladep, N. G., Khan, S. A., Crossey, M. M. E., Thillainayagam, A. V., Taylor-Robinson, S. D., & Toledano, M. B. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i6.1544 · Cited by 38
Moon, S. H., Noh, T. S., Cho, Y. S., Hong, S. P., Hyun, S. H., Choi, J. Y., Kim, B., & Lee, K.-H. (2014) · Angiology · doi:10.1177/0003319714537872 · Cited by 37
Nonalcoholic fatty liver associated with impairment of kidney function in nondiabetes population.
Li, G., Shi, W., Hu, H. Z., Chen, Y., Liu, L., & Yin, D. (2012) · Biochemia Medica · doi:10.11613/bm.2012.010 · Cited by 36
Non-alcoholic Fatty Liver Disease and Chronic Kidney Disease in Koreans Aged 50 Years or Older
Ahn, A.-L., Choi, J., Kim, M. K., Kim, S.-A., Oh, E.-J., Kweon, H.-J., & Cho, D.-Y. (2013) · Korean Journal of Family Medicine · doi:10.4082/kjfm.2013.34.3.199 · Cited by 34
Early left ventricular abnormality/dysfunction in obese children affected by NAFLD
Fintini, D., Chinali, M., Cafiero, G., Esposito, C., Giordano, U., Turchetta, A., Pescosolido, S., Pongiglione, G., & Nobili, V. (2013) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2013.06.005 · Cited by 27
Dunn, M. A., Behari, J., Rogal, S. S., O’Connell, M. R., Furlan, A., Aghayev, A., Gümüş, S., Saul, M. I., & Bae, K. T. (2013) · Liver International · doi:10.1111/liv.12285 · Cited by 25
Serum TAG Analysis Differentiates Between Genetic and Obesity-Associated NAFLD
Mashek, D. G., & Greenberg, A. S. (2013) · Diabetes · doi:10.2337/db13-1500 · Cited by 8
Biomarkers and atrial fibrillation: is it prime time yet?
Mahajan, R., Lau, D. H., & Sanders, P. (2014) · Heart · doi:10.1136/heartjnl-2014-306008 · Cited by 6
Research works printed but not linked: 1
- Konfortion, 2014, Time and deprivation trends in incidence of primary liver cancer subtypes in England, J Eval Clin Pract, 20, 498, 10.1111/jep.12188 · doi:10.1111/jep.12188
Cited by
Chalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., Harrison, S. A., Brunt, E. M., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29367 · Cited by 7,239
Eslam, M., Newsome, P. N., Sarin, S. K., Anstee, Q. M., Targher, G., Romero-Gomez, M., Zelber-Sagi, S., Wai-Sun Wong, V., Dufour, J.-F., Schattenberg, J. M., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.03.039 · Cited by 4,472
Self-citationEstes, C., Razavi, H., Loomba, R., Younossi, Z., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29466 · Cited by 2,399
Younossi, Z. M., Golabi, P., de Avila, L., Paik, J. M., Srishord, M., Fukui, N., Qiu, Y., Burns, L., Afendy, A., & Nader, F. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.06.021 · Cited by 2,235
Estes, C., Anstee, Q. M., Arias-Loste, M. T., Bantel, H., Bellentani, S., Caballeria, J., Colombo, M., Craxi, A., Crespo, J., Day, C. P., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.05.036 · Cited by 1,980
Metadata
- Authors
- Byrne, C. D., & Targher, G.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2015-04
- Volume
- 62
- Issue
- 1
- Pages
- S47-S64
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W2162382402
- Cited by
- 3,042
- References
- 151
- FWCI
- 99.99
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.